Revolutionary Biohybrid Microrobots: A New Hope for Lung Cancer Treatment

Researchers at the University of California, San Diego have developed a green microalgae-based biohybrid microrobot that delivers chemotherapy directly to lung tumors. This innovative approach improves drug efficacy and reduces side effects. Tested in mice, it significantly increased median survival time, showing promise for treating various lung diseases.


PTI | Sandiego | Updated: 14-06-2024 10:22 IST | Created: 14-06-2024 10:22 IST
Revolutionary Biohybrid Microrobots: A New Hope for Lung Cancer Treatment
AI Generated Representative Image

Researchers at the University of California, San Diego have pioneered a groundbreaking method for treating lung cancer using biohybrid microrobots. These microrobots, made from green microalgae and synthetic materials, deliver chemotherapy directly to lung tumors. This targeted approach offers a significant advantage over traditional chemotherapy, which often fails to accumulate in high enough concentrations to be effective.

The innovative microrobots, named algae-NP(DOX)-robots, utilize a natural propulsion mechanism and are biocompatible, reducing toxicity and improving drug delivery efficiency. In studies with mice, the microrobots successfully navigated lung tissues, distributing the drug doxorubicin and avoiding immune system detection. This method resulted in a 40% increase in median survival time for the treated mice.

While these biohybrid microrobots offer a promising new direction for lung cancer treatment, researchers are also exploring their use in other lung-related diseases and enhancing their precision with advanced control strategies. Though clinical application is some time away, this research lays crucial groundwork for future bioengineered cancer therapies.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback